Ascendis Pharma A/S
NASDAQ:ASND
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
90.62
159.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Ascendis Pharma A/S
Current Portion of Long-Term Debt
Ascendis Pharma A/S
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ascendis Pharma A/S
NASDAQ:ASND
|
Current Portion of Long-Term Debt
€21.4m
|
CAGR 3-Years
45%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Current Portion of Long-Term Debt
kr94m
|
CAGR 3-Years
17%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Current Portion of Long-Term Debt
kr15.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Current Portion of Long-Term Debt
kr41.9m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
21%
|
CAGR 10-Years
17%
|
F
|
Fluoguide AS
STO:FLUO
|
Current Portion of Long-Term Debt
kr10.2m
|
CAGR 3-Years
299%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Bioporto A/S
CSE:BIOPOR
|
Current Portion of Long-Term Debt
kr2.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
60%
|
See Also
What is Ascendis Pharma A/S's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
21.4m
EUR
Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Current Portion of Long-Term Debt amounts to 21.4m EUR.
What is Ascendis Pharma A/S's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
35%
Over the last year, the Current Portion of Long-Term Debt growth was -20%. The average annual Current Portion of Long-Term Debt growth rates for Ascendis Pharma A/S have been 45% over the past three years , 35% over the past five years .